CHANGES IN PUTAMEN N-ACETYLASPARTATE AND CHOLINE RATIOS IN UNTREATED AND LEVODOPA-TREATED PARKINSONS-DISEASE - A PROTON MAGNETIC-RESONANCE SPECTROSCOPY STUDY
Cm. Ellis et al., CHANGES IN PUTAMEN N-ACETYLASPARTATE AND CHOLINE RATIOS IN UNTREATED AND LEVODOPA-TREATED PARKINSONS-DISEASE - A PROTON MAGNETIC-RESONANCE SPECTROSCOPY STUDY, Neurology, 49(2), 1997, pp. 438-444
We have carried out single-voxel proton magnetic resonance spectroscop
y centered on the putamen both ipsilateral and contralateral to the wo
rst affected side in nine subjects with drug naive idiopathic Parkinso
n's disease (IPD); seven chronically levodopa-treated dyskinetic IPD s
ubjects; and 11 age-matched healthy controls. Measurements of N-acetyl
aspartate (NAA)/choline (Cho), NAA/(Creatine + Phosphocreatine) (Cr+PC
r), and Cho/(Cr+PCr) were made. We found a significant reduction in NA
A/Cho ratios from the putamen contralateral to the most affected side
in the drug-naive group (p = 0.009), but not the levodopa-treated IPD
groups compared with controls, There were no significant differences i
n NAA/(Cr+PCr) or Cho/(Cr+PCr) ratios. In untreated IPD, reduced putam
inal NAA/Cho ratios may reflect loss of nigrostriatal dopamine termina
ls or alternatively indicate a functional abnormality of striatal puta
minal neurons, such as membrane dysfunction due to striatal deafferent
ation. This study suggests that NAA/Cho ratios may be affected by L-do
pa therapy and this may provide a reversible marker of neuronal dysfun
ction in the striatum.